The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Immunomodulatory drugs and the risk of serious infection in multiple myeloma: systematic review and meta-analysis of randomized and observational studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J.-L., Dmoszynska, A., Miguel, J. S., Hellmann, A., Facon, T., Foà, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070594 · Cited by 1,450
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Komarnicki, M., Suzuki, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607751 · Cited by 1,445
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Stewart, A. K., Rajkumar, S. V., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Mihaylov, G. G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411321 · Cited by 1,332
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Weber, D. M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E. A., Siegel, D., Borrello, I., Rajkumar, S. V., Chanan-Khan, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070596 · Cited by 1,233
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Lauwers-Cances, V., Marit, G., Caillot, D., Moreau, P., Facon, T., Stoppa, A. M., Hulin, C., Benboubker, L., Garderet, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114138 · Cited by 1,155
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114083 · Cited by 1,147
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P., Baker, B. W., Jackson, S. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516282 · Cited by 1,060
Rajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933
Durie, B. G. M., Hoering, A., Abidi, M. H., Rajkumar, S. V., Epstein, J., Kahanic, S. P., Thakuri, M., Reu, F., Reynolds, C. M., Sexton, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31594-x · Cited by 908
Facon, T., Mary, J. Y., Hulin, C., Benboubker, L., Attal, M., Pegourie, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 869
Rajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
Cavo, M., Tacchetti, P., Patriarca, F., Petrucci, M. T., Pantani, L., Galli, M., Di Raimondo, F., Crippa, C., Zamagni, E., Palumbo, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61424-9 · Cited by 819
Palumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Miguel, J. S., Weisel, K., Moreau, P., Lacy, M., Song, K., Delforge, M., Karlin, L., Goldschmidt, H., Banos, A., Oriol, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70380-2 · Cited by 801
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
Palumbo, A., Cavallo, F., Gay, F., Di Raimondo, F., Ben Yehuda, D., Petrucci, M. T., Pezzatti, S., Caravita, T., Cerrato, C., Ribakovsky, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402888 · Cited by 778
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112704 · Cited by 741
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Barlogie, B., Tricot, G., Anaissie, E., Shaughnessy, J., Rasmussen, E., van Rhee, F., Fassas, A., Zangari, M., Hollmig, K., Pineda-Roman, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053583 · Cited by 739
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma
Attal, M., Harousseau, J.-L., Leyvraz, S., Doyen, C., Hulin, C., Benboubker, L., Agha, I. Y., Bourhis, J.-H., Garderet, L., Pegourie, B., et al. (2006) · Blood · doi:10.1182/blood-2006-05-022962 · Cited by 667
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648
Assessing the Quality of Randomized Trials
Clark, H. D., Wells, G. A., Huët, C., McAlister, F. A., Salmi, L. R., Fergusson, D., & Laupacis, A. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00026-4 · Cited by 648
Röllig, C., Knop, S., & Bornhäuser, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60493-1 · Cited by 603
Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma
Weber, D., Rankin, K., Gavino, M., Delasalle, K., & Alexanian, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.139 · Cited by 566
Augustson, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A., & Drayson, M. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2086 · Cited by 488
Rosiñol, L., Oriol, A., Teruel, A. I., Hernández, D., López-Jiménez, J., de la Rubia, J., Granell, M., Besalduch, J., Palomera, L., González, Y., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408922 · Cited by 486
Mateos, M.-V., Oriol, A., Martínez-López, J., Gutiérrez, N., Teruel, A.-I., de Paz, R., García-Laraña, J., Bengoechea, E., Martín, A., Mediavilla, J. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70187-x · Cited by 458
Kumar, S., Flinn, I., Richardson, P. G., Hari, P., Callander, N., Noga, S. J., Stewart, A. K., Turturro, F., Rifkin, R., Wolf, J., et al. (2012) · Blood · doi:10.1182/blood-2011-11-395749 · Cited by 446
Palumbo, A., Bringhen, S., Rossi, D., Cavalli, M., Larocca, A., Ria, R., Offidani, M., Patriarca, F., Nozzoli, C., Guglielmelli, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.8216 · Cited by 423
Cavo, M., Zamagni, E., Tosi, P., Tacchetti, P., Cellini, C., Cangini, D., de Vivo, A., Testoni, N., Nicci, C., Terragna, C., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0522 · Cited by 369
Rajkumar, S. V., Rosiñol, L., Hussein, M., Catalano, J., Jedrzejczak, W., Lucy, L., Olesnyckyj, M., Yu, Z., Knight, R., Zeldis, J. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1853 · Cited by 343
Spencer, A., Prince, H. M., Roberts, A. W., Prosser, I. W., Bradstock, K. F., Coyle, L., Gill, D. S., Horvath, N., Reynolds, J., & Kennedy, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8573 · Cited by 332
Palumbo, A., Falco, P., Corradini, P., Falcone, A., Di Raimondo, F., Giuliani, N., Crippa, C., Ciccone, G., Omedè, P., Ambrosini, M. T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3463 · Cited by 319
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Lacy, M. Q., Hayman, S. R., Gertz, M. A., Dispenzieri, A., Buadi, F., Kumar, S., Greipp, P. R., Lust, J. A., Russell, S. J., Dingli, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6802 · Cited by 317
Gay, F., Oliva, S., Petrucci, M. T., Conticello, C., Catalano, L., Corradini, P., Siniscalchi, A., Magarotto, V., Pour, L., Carella, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00389-7 · Cited by 314
Moreau, P., Avet-Loiseau, H., Facon, T., Attal, M., Tiab, M., Hulin, C., Doyen, C., Garderet, L., Randriamalala, E., Araujo, C., et al. (2011) · Blood · doi:10.1182/blood-2011-05-355081 · Cited by 303
Lonial, S., Vij, R., Harousseau, J.-L., Facon, T., Moreau, P., Mazumder, A., Kaufman, J. L., Leleu, X., Tsao, L. C., Westland, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2649 · Cited by 296
Moreau, P., Hulin, C., Macro, M., Caillot, D., Chaleteix, C., Roussel, M., Garderet, L., Royer, B., Brechignac, S., Tiab, M., et al. (2016) · Blood · doi:10.1182/blood-2016-01-693580 · Cited by 278
Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71125-8 · Cited by 262
Wijermans, P., Schaafsma, M., Termorshuizen, F., Ammerlaan, R., Wittebol, S., Sinnige, H., Zweegman, S., van Marwijk Kooy, M., van der Griend, R., Lokhorst, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1610 · Cited by 260
Li, L., Li, S., Deng, K., Liu, J., Vandvik, P. O., Zhao, P., Zhang, L., Shen, J., Bala, M. M., Sohani, Z. N., et al. (2016) · BMJ · doi:10.1136/bmj.i610 · Cited by 238
Curing myeloma at last: defining criteria and providing the evidence
Barlogie, B., Mitchell, A., van Rhee, F., Epstein, J., Morgan, G. J., & Crowley, J. (2014) · Blood · doi:10.1182/blood-2014-07-552059 · Cited by 235
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
Waage, A., Gimsing, P., Fayers, P., Abildgaard, N., Ahlberg, L., Björkstrand, B., Carlson, K., Dahl, I. M., Forsberg, K., Gulbrandsen, N., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237974 · Cited by 230
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Shah, J. J., Stadtmauer, E. A., Abonour, R., Cohen, A. D., Bensinger, W. I., Gasparetto, C., Kaufman, J. L., Lentzsch, S., Vogl, D. T., Gomes, C. L., et al. (2015) · Blood · doi:10.1182/blood-2015-05-643320 · Cited by 226
Multiple myeloma: 2014 Update on diagnosis, risk‐stratification, and management
Rajkumar, S. V. (2014) · American Journal of Hematology · doi:10.1002/ajh.23810 · Cited by 208
Ludwig, H., Hajek, R., Tóthová, E., Drach, J., Adam, Z., Labar, B., Egyed, M., Spicka, I., Gisslinger, H., Greil, R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-169565 · Cited by 208
Leleu, X., Attal, M., Arnulf, B., Moreau, P., Traulle, C., Marit, G., Mathiot, C., Petillon, M. O., Macro, M., Roussel, M., et al. (2013) · Blood · doi:10.1182/blood-2012-09-452375 · Cited by 206
Morgan, G. J., Davies, F. E., Gregory, W. M., Russell, N. H., Bell, S. E., Szubert, A. J., Coy, N. N., Cook, G., Feyler, S., Byrne, J. L., et al. (2011) · Blood · doi:10.1182/blood-2011-02-338665 · Cited by 198
Zonder, J. A., Crowley, J., Hussein, M. A., Bolejack, V., Moore, D. F., Whittenberger, B. F., Abidi, M. H., Durie, B. G. M., & Barlogie, B. (2010) · Blood · doi:10.1182/blood-2010-08-303487 · Cited by 194
Cavo, M., Zamagni, E., Tosi, P., Cellini, C., Cangini, D., Tacchetti, P., Testoni, N., Tonelli, M., Vivo, A. D., Palareti, G., et al. (2004) · PubMed · Cited by 191
Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4918 · Cited by 190
Niesvizky, R., Jayabalan, D. S., Christos, P. J., Furst, J. R., Naib, T., Ely, S., Jalbrzikowski, J., Pearse, R. N., Zafar, F., Pekle, K., et al. (2008) · Blood · doi:10.1182/blood-2007-05-090258 · Cited by 184
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
Palumbo, A., Ambrosini, M. T., Benevolo, G., Pregno, P., Pescosta, N., Callea, V., Cangialosi, C., Caravita, T., Morabito, F., Musto, P., et al. (2007) · Blood · doi:10.1182/blood-2006-08-042275 · Cited by 182
Richardson, P. G., Xie, W., Jagannath, S., Jakubowiak, A., Lonial, S., Raje, N. S., Alsina, M., Ghobrial, I. M., Schlossman, R. L., Munshi, N. C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-517276 · Cited by 182
Lee, C.-K., Barlogie, B., Munshi, N., Zangari, M., Fassas, A., Jacobson, J., van Rhee, F., Cottler-Fox, M., Muwalla, F., & Tricot, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.055 · Cited by 175
Dimopoulos, M. A., Palumbo, A., Corradini, P., Cavo, M., Delforge, M., Di Raimondo, F., Weisel, K. C., Oriol, A., Hansson, M., Vacca, A., et al. (2016) · Blood · doi:10.1182/blood-2016-02-700872 · Cited by 165
Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens
Niesvizky, R., Flinn, I. W., Rifkin, R. M., Gabrail, N. Y., Charu, V., Clowney, B., Essell, J. H., Gaffar, Y., Warr, T. A., Neuwirth, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.7618 · Cited by 162
Morgan, G. J., Davies, F. E., Gregory, W. M., Bell, S. E., Szubert, A. J., Navarro Coy, N., Cook, G., Feyler, S., Johnson, P. R. E., Rudin, C., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.043372 · Cited by 160
García-Sanz, R., González-Porras, J. R., Hernández, J. M., Polo-Zarzuela, M., Sureda, A., Barrenetxea, C., Palomera, L., López, R., Grande-García, C., Alegre, A., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403322 · Cited by 159
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Kristinsson, S. Y., Tang, M., Pfeiffer, R. M., Björkholm, M., Goldin, L. R., Blimark, C. H., Mellqvist, U. H., Wåhlin, A., Turesson, I., & Landgren, O. (2011) · Haematologica · doi:10.3324/haematol.2011.054015 · Cited by 149
Baz, R., Walker, E., Karam, M. A., Choueiri, T. K., Jawde, R. M. A., Bruening, K., Reed, J., Faiman, B. M., Ellis, Y., Brand, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl313 · Cited by 147
Beksaç, M., Haznedar, R., Firatli‐Tuglular, T., Özdoğu, H., Aydoğdu, İ., Konuk, N., Sucak, G. T., Kaygusuz, I., Karakuş, S., Kaya, E., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01524.x · Cited by 143
Stewart, A. K., Trudel, S., Bahlis, N. J., White, D. J., Sabry, W., Belch, A. R., Reiman, T., Roy, J., Shustik, C., Kovacs, M. J., et al. (2013) · Blood · doi:10.1182/blood-2012-09-451872 · Cited by 142
Knop, S. T., Gerecke, C., Liebisch, P., Topp, M. S., Platzbecker, U., Sezer, O., Vollmuth, C., Falk, K., Glasmacher, A., Maeder, U., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184135 · Cited by 133
Wang, M. L., Martin, T. G., Bensinger, W., Alsina, M., Siegel, D. S. D., Kavalerchik, E., Huang, M., Orlowski, R. Z., & Niesvizky, R. (2013) · Blood · doi:10.1182/blood-2013-07-511170 · Cited by 131
Zervas, K., Dimopoulos, M. A., Hatzicharissi, E., Anagnostopoulos, Α., Papaioannou, M., Mitsouli, C., Panagiotidis, P., Korantzis, J., Tzilianos, M., & Maniatis, A. G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdh026 · Cited by 126
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
Wang, M., Giralt, S., Delasalle, K. B., Handy, B. C., & Alexanian, R. (2007) · Hematology · doi:10.1080/10245330701214236 · Cited by 117
Terpos, E., Mihou, D., Szydlo, R., Tsimirika, K., Karkantaris, C., Politou, M., Voskaridou, E., Rahemtulla, A., Dimopoulos, M. A., & Zervas, K. (2005) · Leukemia · doi:10.1038/sj.leu.2403890 · Cited by 106
Badros, A. Z., Goloubeva, O. G., Rapoport, A. P., Ratterree, B., Gahres, N., Meisenberg, B. R., Takebe, N., Heyman, M. R., Zwiebel, J. A., STREICHER, H. Z., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.381 · Cited by 101
Magarotto, V., Bringhen, S., Offidani, M., Benevolo, G., Patriarca, F. F., Mina, R., Falcone, A. P., Paoli, L. D., Pietrantuono, G., Gentili, S., et al. (2016) · Blood · doi:10.1182/blood-2015-08-662627 · Cited by 93
Larocca, A., Montefusco, V., Bringhen, S., Rossi, D., Crippa, C., Mina, R., Galli, M., Marcatti, M., Verde, G. L., Giuliani, N., et al. (2013) · Blood · doi:10.1182/blood-2013-03-488676 · Cited by 90
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma
Palumbo, A., Bertola, A., Musto, P., Caravita, T., Callea, V., Nunzi, M., Grasso, M., Falco, P., Cangialosi, C., & Boccadoro, M. (2005) · Cancer · doi:10.1002/cncr.21342 · Cited by 84
Dimopoulos, M. A., Weisel, K. C., Song, K., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Baños, A., Oriol, A., Garderet, L., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117077 · Cited by 75
Zervas, K., Mihou, D., Katodritou, E., Pouli, A. G., Mitsouli, C., Anagnostopoulos, Α., Delibasi, S., Kyrtsonis, M., Anagnostopoulos, N., Terpos, E., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm178 · Cited by 71
Teh, B. W., Harrison, S. J., Worth, L. J., Thursky, K., & Slavin, M. A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.07.025 · Cited by 71
Ludwig, H., Adam, Z., Tóthová, E., Hájek, R., Labar, B., Egyed, M., Špıčka, I., Gisslinger, H., Drach, J. W., Kühn, I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.020586 · Cited by 70
Stewart, A. K., Chen, C. I., Howson‐Jan, K., White, D. J., Roy, J., Kovacs, M. J., Shustik, C., Sadura, A., Shepherd, L. E., Ding, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1106 · Cited by 67
Teh, B. W., Harrison, S. J., Pellegrini, M., Thursky, K., Worth, L. J., & Slavin, M. A. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.01.004 · Cited by 61
Kropff, M. H., Baylon, H. G., Hillengaß, J., Robak, T., Hájek, R., Liebisch, P., Goranova-Marinova, V. S., Hulin, C., Bladé, J., Caravita, T., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.044271 · Cited by 61
Hou, J., Du, X., Jin, J., Cai, Z., Chen, F., Zhou, D.-B., Yu, L., Ke, X., Li, X., Wu, D., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-41 · Cited by 50
Li, Y., YinHui, T., Yunliang, Z., & Sun, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16235 · Cited by 48
Hassoun, H., REICH, L. M., Klimek, V. M., Dhodapkar, M. V., Cohen, A. D., Kewalramani, T., Zimman, R., Drake, L., Riedel, E., Hedvat, C. V., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05848.x · Cited by 45
Offidani, M., Polloni, C., Cavallo, F., Liberati, A. M., Ballanti, S., Pulini, S., Catarini, M., Alesiani, F., Corvatta, L., Gentili, S., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.664844 · Cited by 45
Palumbo, A. P., Larocca, A., Genuardi, M., Kotwica-Mojzych, K., Gay, F., Rossi, D., Benevolo, G., Magarotto, V., Cavallo, F., Bringhen, S., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.017913 · Cited by 43
Berenson, J. R., Yellin, O., Kazamel, T., Hilger, J. D., Cheng, C., Cartmell, A., Woliver, T. B. S., Flam, M. S., Bravin, E., Nassir, Y., et al. (2012) · Leukemia · doi:10.1038/leu.2012.51 · Cited by 41
Ciolli, S., Leoni, F., Casini, C., Breschi, C., Santini, V., & Bosi, A. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07147.x · Cited by 40
Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma
Wang, M. L., Weber, D. M., Delasalle, K. B., & Alexanian, R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20382 · Cited by 39
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma*
Waage, A., Gimsing, P., Juliusson, G., Turesson, I., Gulbrandsen, N., Eriksson, T., Hjorth, M., Nielsen, J. L., Lenhoff, S., Westin, J., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04879.x · Cited by 36
Schütt, P., Ebeling, P. R., Buttkereit, U., Brandhorst, D., Opalka, B., Poser, M., Müller, S., Flaßhove, M., Moritz, T., Seeber, S., et al. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1007-7 · Cited by 33
Jung, S., Jang, H., Lee, S.-S., Ahn, J., Yang, D., Kim, Y., Kim, H., & Lee, J. (2014) · BioMed Research International · doi:10.1155/2014/413149 · Cited by 32
Hovenga, S., Daenen, S. M. G. J., de Wolf, J. T. M., Imhoff, G. W. V., Kluin‐Nelemans, H. C., Sluiter, W. J., & Vellenga, E. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0981-5 · Cited by 31
Alegre, A. M., Oriol, A., García‐Laraña, J., Mateos, M., Sureda, A. M., Martínez‐Chamorro, C., Cibeira, M. T., Aguado, B., Knight, R., & Rosettani, B. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.662643 · Cited by 31
A threshold analysis assessed the credibility of conclusions from network meta-analysis
Caldwell, D. M., Ades, A. E., Dias, S., Watkins, S., Li, T., Taske, N., Naidoo, B., & Welton, N. J. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.003 · Cited by 28
Mey, U., Brugger, W., Schwarb, H., Pederiva, S., Schwarzer, A., Dechow, T. N., Jehner, P., Rauh, J., Taverna, C., Schmid, M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14481 · Cited by 23
A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myeloma
Bensinger, W., Green, D. J., Burwick, N. R., & Becker, P. S. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.219 · Cited by 21
Sahebi, F., Frankel, P. H., Farol, L., Krishnan, A. Y., Cai, J., Somlo, G., Thomas, S. H., Reburiano, E., Popplewell, L. L., Parker, P. M., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.12.580 · Cited by 18
Offidani, M., Corvatta, L., Polloni, C., Gentili, S., Mele, A., Rizzi, R., Catarini, M., Caraffa, P., Samorì, A., Blasi, N., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1217-0 · Cited by 18
Ichinohe, T., Kuroda, Y., Okamoto, S., Matsue, K., Iida, S., Sunami, K., Komeno, T., Suzuki, K., Ando, K., Taniwaki, M., et al. (2015) · Experimental Hematology and Oncology · doi:10.1186/s40164-016-0040-7 · Cited by 18
Martino, M. V., Console, G., Callea, V., Stelitano, C. C., Massara, E., Irrera, G., Messina, G., Morabito, F., & Iacopino, P. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00774.x · Cited by 16
Suzuki, K., Shinagawa, A., Uchida, T., Taniwaki, M., Hirata, H., Ishizawa, K., Matsue, K., Ogawa, Y., Shimizu, T., Otsuka, M., et al. (2016) · Cancer Science · doi:10.1111/cas.12916 · Cited by 14
Zamagni, E., Petrucci, A., Tosi, P., Tacchetti, P., Perrone, G., Brioli, A., Pantani, L., Zannetti, B. A., Terragna, C., Baccarani, M., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1320-2 · Cited by 13
Guo, H., Xin Min, Z. H. O. U., Jiang, Y., Yang, G., Sun, C., Zhuang, Y., Sun, H., Lu, M., Qian, X., Chen, F., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21734 · Cited by 13
Chiou, T.-J., Wang, T.-H., Chao, T.-Y., Lin, S.-F., Tang, J., Chen, T., Chang, M., Hsueh, E.-J., & Chen, P. (2007) · Cancer Investigation · doi:10.1080/07357900701208808 · Cited by 13
Teoh, G., Chen, Y., Kım, K., Srivastava, A., Pai, V. R., Yoon, S., Suh, C., & Kim, Y. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.11.002 · Cited by 7
Cited by
Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M.-V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, A. J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0876-z · Cited by 736
(2018) · PubMed · Cited by 4
Metadata
- Authors
- Chen, M., Zhao, Y., Xu, C., Wang, X., Zhang, X., & Mao, B.
- Venue
- Annals of Hematology
- Published
- 2018-03-02
- Volume
- 97
- Issue
- 6
- Pages
- 925-944
- ISSN
- 0939-5555 (ISSN-L)
- 1432-0584
- OpenAlex
- W2791309620
- Cited by
- 647
- References
- 108
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.